Research Progress on the Pathogenic Mechanisms of α-Synuclein and Related Disease Models
DOI:
CSTR:
Author:
Affiliation:

1.School of Medicine, Foshan University, Guangdong Research Center of Gene Editing Engineering Technology;2.School of Medicine,Foshan University,Guangdong Research Center of Gene Editing Engineering Technology;3.GuangDong GemPharmatech Co., Ltd.

Clc Number:

Fund Project:

National Key Research and Development Program (2021YFA0805901), National Natural Science Foundation of China (82070199), Guangdong Provincial Basic and Applied Basic Research Foundation (2021A1515220078), Guangxi Key Research and Development Program (2024AB04008).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The core pathological feature of Parkinson's Disease (PD) is the abnormal aggregation of α-synuclein and the resulting neuronal damage. α-Synuclein exhibits toxic effects when it forms oligomers or fibrils, leading to neuronal death through multiple pathways, including mitochondrial dysfunction, impaired vesicular trafficking, dopamine auto-oxidation, and neuroinflammation. Additionally, α-synuclein can propagate between cells via exosomes, endocytosis/exocytosis, tunneling nanotubes (TNTs), or vagal nerve axonal transport, creating a cascade of pathological effects. This article systematically reviews the structure and function of α-synuclein, its mechanisms of toxicity, intercellular propagation pathways, animal models of overexpression, and potential therapeutic targets based on its pathogenic mechanisms.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 09,2025
  • Revised:August 01,2025
  • Adopted:September 05,2025
  • Online:
  • Published:
Article QR Code